Abstract:Porcine mucosal heparin was partially depolymerized with heparin lyase I and then fractionated into low-molecular-weight (< 5000) and high-molecular-weight (> 5000) oligosaccharides by pressure filtration. The high-molecular-weight oligosaccharide mixture (approximately 50 wt% of the starting heparin) also contained intact heparin. This intact polymer complicates oligosaccharide purification. Thus, the low-molecular-weight fraction was used to prepare homogeneous oligosaccharides for structural characterization. The low-molecular-weight oligosaccharide mixture was first fractionated by low-pressure gel permeation chromatography into size-uniform mixtures of disaccharides, tetrasaccharides, hexasaccharides, octasaccharides, decasaccharides, dodecasaccharides, tetradecasaccharides and higher oligosaccharides. Each size-fractionated mixture was then purified on the basis of charge by repetitive semi-preparative strong-anion-exchange high-performance liquid chromatography. This approach has led to the isolation of 14 homogeneous oligosaccharides from disaccharide to tetradecasaccharide. The purity of these heparin-derived oligosaccharides was determined by gradient polyacrylamide gel electrophoresis, analytical strong-anion-exchange high-performance liquid chromatography, capillary electrophoresis and one-dimensional nuclear resonance spectroscopy. The structure of these oligosaccharides was established using 600 MHz two-dimensional nuclear resonance spectroscopy. The spectral methods used included homonuclear correlation spectroscopy, nuclear Overhauser effect spectroscopy and heteronuclear multiple quantum coherence spectroscopy. The 1H/1H connectivities of the protons of each sugar residue in an oligosaccharide were established by two-dimensional homonuclear correlation spectroscopy, while 1H/13C assignments were made using 1H inverse detection. One- and two-dimensional nuclear resonance spectroscopic analysis of these heparin oligosaccharides showed two closely related groups of heparin-oligosaccharides are afforded by enzymatic depolymerization of heparin. One group is fully sulphated, having the structures delta UAp2S(1[-->4)-alpha-D-GlcNpS6S(1-->4)-alpha-L-IdoAp2S( 1]n-->4)-alpha- D-GlcNpS6S, where delta UAp is 4-deoxy-alpha-L-threo-hex-4-eno-pyranosyluronic acid, GlcNp is 2-deoxy-2-aminoglucopyranose, IdoAp is idopyranosyluronic acid, S is sulphate and n = 0-6. The other group of oligosaccharides differ in that they contain beta-D-glucuronic acid in place of the alpha-L-iduronic acid residue nearest to the reducing end. The present study describes the isolation and structural elucidation of seven new oligosaccharides: an octasaccharide, two decasaccharides, two dodecasaccharides and two tetradecasaccharides. The utility of two-dimensional nuclear resonance spectroscopy to determine the structure of complex heparin oligosaccharides is also illustrated.

Heparin Mapping Using Heparin Lyases and the Generation of a Novel Low Molecular Weight Heparin

HeparinMappingUsingHeparin Lyases and theGeneration of aNovel LowMolecularWeightHeparin

Comprehensive Identification and Quantitation of Basic Building Blocks for Low-Molecular Weight Heparin.

Profiling Analysis of Low Molecular Weight Heparins by Multiple Heart-Cutting Two Dimensional Chromatography with Quadruple Time-of-flight Mass Spectrometry.

Enzymatic synthesis of low molecular weight heparins from N-sulfo heparosan depolymerized by heparanase or heparin lyase

Sequencing the Oligosaccharide Pool in the Low Molecular Weight Heparin Dalteparin with Offline HPLC and ESI–MS/MS

Antithrombin III-Binding Site Analysis of Low-Molecular-Weight Heparin Fractions

Liquid Chromatography–diode Array Detection–mass Spectrometry for Compositional Analysis of Low Molecular Weight Heparins

Quantitative Analysis of the Major Linkage Region Tetrasaccharides in Heparin

Fragment Profiling of Low Molecular Weight Heparins Using Reversed Phase Ion Pair Liquid Chromatography-Electrospray Mass Spectrometry.

Bottom-up low molecular weight heparin analysis using liquid chromatography-Fourier transform mass spectrometry for extensive characterization.

Structure and Activity of a New Low-Molecular-weight Heparin Produced by Enzymatic Ultrafiltration.

Heparinase 1 Selectivity For The 3,6-Di-O-Sulfo-2-Deoxy-2-Sulfamido-Alpha-D-Glucopyranose (1,4) 2-O-Sulfo-Alpha-L-Idopyranosyluronic Acid (Glcns3s6s-Idoa2s) Linkages

Heparinase 1 selectivity for the 3,6-di-O-sulfo-2-deoxy-2-sulfamido- -D-glucopyranose (1,4) 2-O-sulfo- -L-idopyranosyluronic acid (GlcNS3S6S-IdoA2S) linkages

Glycan Mapping of Low-Molecular-Weight Heparin Using Mass Spectral Correction Based on Chromatography Fitting with "glycomapping" Software.

Analysis of heparinase derived LMWH products using a MHC 2D LC system linked to Q-TOF MS

Comprehensive Analysis of Heparinase Derived Heparin-Products Using Two-Dimensional Liquid Chromatography Coupled with Mass Spectrometry.

Homogeneous Low-Molecular-weight Heparins with Reversible Anticoagulant Activity

Enzymatic access to the rare ΔUA (1→4) Glc 3, 6, N-sulfated heparin disaccharide, implications for heparin quality control

Preparation and structural characterization of large heparin-derived oligosaccharides

Oligosaccharides Mapping of Nitrous Acid Degraded Heparin Through UHPLC-HILIC/WAX-MS.